Söndag 27 April | 06:36:10 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-12 08:30 Bokslutskommuniké 2025
2025-10-23 08:30 Kvartalsrapport 2025-Q3
2025-08-21 08:30 Kvartalsrapport 2025-Q2
2025-05-16 N/A X-dag ordinarie utdelning NANECH 0.00 SEK
2025-05-15 N/A Årsstämma
2025-04-30 08:30 Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-04-30 - Kvartalsrapport 2024-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
NanoEcho är verksamt inom sjukvården, med huvudsaklig fokus inom rektalcancerdiagnostik. Bolaget är verksamt i kliniskt skede, där man utvecklar en ny diagnostisk metod för att fastställa om tidig rektalcancer har spridit sig till närliggande lymfkörtlar. Metoden ämnar ge en korrekt diagnos och individanpassad behandling. NanoEcho grundades år 2013 och har sitt huvudkontor i Lund.
2022-10-19 08:30:00

As part of the company's development, NanoEcho is strengthening the organisation by adding regulatory expertise to the management team. Kristina Hallström will bear responsibility for Quality Assurance and Regulatory Affairs, with a particular focus on market approval for NanoEcho's system.

Kristina Hallström, Head of Marketing and Communication at NanoEcho, now has an expanded remit. She boasts extensive experience in working strategically with clinical issues and regulatory matters. In recent years, she has been active as a medical technology consultant with a clinical and regulatory focus. At NanoEcho, Kristina will work actively together with clinics, product developers and authorities, all with a view to securing market approval for NanoEcho's system.

Kristina has taken on this assignment gradually. During the autumn, the company worked on developing a regulatory strategy, selected a Notified Body to certify the quality management system, and applied for – and was granted – a Vinnova grant for regulatory work.

'I am very happy that Kristina has chosen to expand her corporate responsibility and also taken on this key regulatory work. I feel we are in safe hands with Kristina in the management team, where she is a great asset and contributes on many fronts with the breadth and depth of her experience,' says Linda Persson, CEO at NanoEcho.

'It will be exciting to drive the process of getting market approval for our system – something we do by showing, step by step, that our system is both clinically useful and meets all the authorities' requirements,' says Kristina Hallström.

Since October 17, Kristina has been working full-time at the company with responsibility for Marketing, Communications, Regulatory Affairs and Quality Assurance.